TCM
TNDM icon

TimesSquare Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

TimesSquare Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-546,465
Closed -$26.1M – 194
2022
Q3 		$26.1M Buy
546,465
+237,170
+77% +$13M 0.36% 124
2022
Q2 		$18.3M Buy
309,295
+3,500
+1% +$287K 0.26% 143
2022
Q1 		$35.6M Sell
305,795
-63,850
-17% -$7.45M 0.4% 108
2021
Q4 		$55.6M Sell
369,645
-60,700
-14% -$8.19M 0.49% 86
2021
Q3 		$51.4M Sell
430,345
-167,855
-28% -$18.5M 0.45% 94
2021
Q2 		$58.3M Sell
598,200
-8,600
-1% -$767K 0.48% 87
2021
Q1 		$53.5M Sell
606,800
-36,500
-6% -$3.39M 0.46% 99
2020
Q4 		$61.6M Buy
643,300
+64,270
+11% +$6.62M 0.5% 82
2020
Q3 		$65.7M Sell
579,030
-257,415
-31% -$27M 0.62% 56
2020
Q2 		$82.7M Sell
836,445
-40,130
-5% -$3.2M 0.79% 32
2020
Q1 		$56.4M Sell
876,575
-423,435
-33% -$29.7M 0.67% 47
2019
Q4 		$77.5M Buy
1,300,010
+60,475
+5% +$3.73M 0.69% 41
2019
Q3 		$73.1M Buy
1,239,535
+102,758
+9% +$6.56M 0.65% 48
2019
Q2 		$73.3M Sell
1,136,777
-108,738
-9% -$7.02M 0.56% 61
2019
Q1 		$79.1M Sell
1,245,515
-395,055
-24% -$20.8M 0.61% 57
2018
Q4 		$62.3M Buy
1,640,570
+548,070
+50% +$19.4M 0.54% 73
2018
Q3 		$46.8M Buy
+1,092,500
New +$38.2M 0.31% 128

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TimesSquare Capital Management's TNDM Position: Q4 2022 in Review

TimesSquare Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 546,465 shares — an estimated $26.1M sold.

TimesSquare Capital Management first reported a position in TNDM in Q3 2018 and held it in 17 quarters. The position peaked at $82.7M in Q2 2020. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • TimesSquare Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 546,465 Tandem Diabetes Care shares in Q4 2022, an estimated $26.1M.
  • TimesSquare Capital Management first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 17 quarters.
  • TimesSquare Capital Management's Tandem Diabetes Care position peaked at $82.7M in Q2 2020.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on TimesSquare Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.